Order results by:
| Issue | Title | |
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... group, the positive dynamics of risk was demonstrated with the electronic version of the SCORE scale ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... , hypercholesterolemia) and various CV risk (SCORE) were included in the one- stage clinical trial. All patients were ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... using Propensity Score Matching. Material and methods. 262 patients aged 60.1±8.9 years, taking statins ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... -DAPT hemorrhagic risk score had a history of renal pathology (р=0.010), multivessel coronary artery ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
| M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
| "... cardiovascular risk (SCORE scale >5%) aged 30-59 y.o. were included in the study. Questionnaire survey, blood ..." | ||
| Vol 14, No 3 (2018) | ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| D. B. Nemik, G. V. Matyushin, S. A. Ustyugov | ||
| "... . Stratification of high-risk patients with STEMI during primary angiography based on the SYNTAX Score scale has ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... cardiovascular risk by 38.1%. In the absence of preventive measures cardiovascular risk, predicted by the SCORE ..." | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... . On the contrary, the non-HDL-C was associated with CVD combined end pints. It has been shown that the risk ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... Conception of total cardio-vascular risk plays important role in defining tactics of arterial ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... Aim. To study the prognostic value of the ORACLE risk score for assessing the risk of bleeding ..." | ||
| Vol 19, No 2 (2023) | Evolution of CHA2DS2-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation | Abstract similar documents |
| A. O. Rubanenko | ||
| "... scores that predict stroke risk,butthe most popular is CHA2DS2-VASc risk score. At the same time ..." | ||
| Vol 19, No 2 (2023) | Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? | Abstract similar documents |
| I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva | ||
| "... Aim. To compare different scores in assessment of risk of left atrial or its appendage thrombosis ..." | ||
| Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
| A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
| "... to cardiovascular risk stratification using the SCORE-2 scale and the likelihood of familial hypercholesterolemia ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| "... , 38 women); 3rd – elder than 65 y.o. (11 men, 34 women). Fatal CV risk according to SCORE scale ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 6, No 3 (2010) | BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS | Abstract similar documents |
| J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal | ||
| "... Blumenthal screening for cardiovascular risk in asymptomatic patients. ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... complications (CVC). Material and methods. 101 patients with HT of 1-2 stage, HH and high risk of CVC (SCORE>5 ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... score for perindopril monotherapy was 9.64, for a fixed combination of perindopril/indapamide – 9 ..." | ||
| Vol 19, No 1 (2023) | Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... with atrial fibrillation and high risk of bleeding. An evidence base is presented demonstrating the high ..." | ||
| Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 17, No 3 (2021) | Thrombolytic Therapy in Treatment in Patients with Pulmonary Embolism not High-risk: SIRENA Registry Data | Abstract similar documents |
| N. A. Cherepanova, I. S. Mullova, T. V. Pavlova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Schmidt, D. V. Duplyakov | ||
| "... risk" (shock or hypotension). In 101 not high risk patients, the indications for TLT were: severe ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... in patients of different age groups, belonging to the category of high and extremely high cardiovascular risk ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..." | ||
| Vol 4, No 4 (2008) | INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK | Abstract similar documents |
| N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky | ||
| "... Estimation of cardiovascular risk is discussed. Serum lipoproteins, glucose, fibrinogen, von ..." | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... that increased BP variability is an independent prognostic factor that increases the risk of cardiovascular ..." | ||
| Vol 8, No 4 (2012) | COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS» | similar documents |
| D. V. Nebieridze | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..." | ||
| Vol 20, No 2 (2024) | Clinical and prognostic value of the MELD-XI score in hospitalized patients with chronic heart failure | Abstract similar documents |
| N. A. Dragomiretskaya, V. I. Podzolkov, A. V. Tolmacheva, I. I. Shvedov, M. V. Vetluzhskaya, V. D. Chistyakova | ||
| "... , the threshold value of the MELD-XI index for high risk of death was 11.4 points (sensitivity 62.73%, specificity ..." | ||
| Vol 4, No 5 (2008) | CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| D. A. Poddubnyy, A. P. Rebrov | ||
| "... of fatal cardiovascular event (SCORE scale) was calculated. Additionally the follows cardiovascular risk ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... to the increase in CVD risk according to SCORE and PROCAM scales. A higher CVD risk on the SCORE scale was found ..." | ||
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| Vol 9, No 4 (2013) | STATINS AND THE RISK OF DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina | ||
| "... the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... with high and very high cardiovascular risk (CVR) in real clinical practice based on the data of the study ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| Vol 8, No 2 (2012) | SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY | Abstract similar documents |
| E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa | ||
| "... %) patients had a high risk of death according to the ESC criteria, and 51 (80%) — an intermediate risk. PE ..." | ||
| Vol 2, No 3 (2006) | COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS | Abstract similar documents |
| O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova | ||
| "... is very important in prevention of cardiovascular complications especially in high risk patients. ..." | ||
| Vol 19, No 5 (2023) | Non-immunogenic staphylokinase in the treatment of high-risk massive pulmonary embolism in the early postoperative period due to femoral fragment wound | Abstract similar documents |
| S. L. Konstantinov, G. I. Stryabkova, A. I. Basarab, V. N. Kravchuk, I. V. Kаzhanov, S. V. Ivanov, Zh. Yu. Chefranova, S. S. Markin | ||
| "... mg bolus over 15 s in a patient with a high-risk massive pulmonary embolism (PE) in the early ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... guidelines for management of patients with high cardiovascular risk; 2) common perception that isolated ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... Society statement stated that the threshold value of Lp(a) for "excluding" the risk of atherosclerotic ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... treatment stages in patients at high and very high cardiovascular risk during 2011-2015. Material ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... high cardiovascular risk in routine clinical practice, as well as the possible impact of educational ..." | ||
| Vol 12, No 3 (2016) | EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva | ||
| "... толщину комплекса интима-медиа (ТКИМ). Результаты. Больные с ИАГ >30 эпизодов/час имели более высокие ..." | ||
| Vol 16, No 3 (2020) | Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics? | Abstract similar documents |
| S. G. Kanorskii | ||
| "... risk of cardiovascular death and disabling vascular events, including stroke, myocardial infarction ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... risk requires widespread use of combined therapy. Current approaches to selection of combination ..." | ||
| Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
| Vol 8, No 5 (2012) | HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... Aim. To study relationship between heart rate (HR) and traditional risk factors for cardiovascular ..." | ||
| Vol 8, No 4 (2012) | RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS | similar documents |
| S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz | ||
| "... высоким сердечно-сосудистым риском с критериями включения, аналогичными исследованию HOPE (Heart Outcomes ..." | ||
| Vol 3, No 3 (2007) | MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA | Abstract similar documents |
| N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich | ||
| "... Maximal reduction of cardiovascular complications risk – the main task of modern therapy for high ..." | ||
| Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
| N. V. Perova, V. A. Metelskaya | ||
| "... Approaches to the total cardiovascular risk calculation based on the actual clinical ..." | ||
| Vol 19, No 5 (2023) | Association of breast arterial calcification and carotid atherosclerosis as a marker of cardiovascular risk | Abstract similar documents |
| E. V. Bochkareva, E. K. Butina, N. Kh. Bayramkulova, I. V. Kim, O. V. Molchanova, E. M. Filichkina, E. B. Yarovaya, V. A. Metelskaya, O. M. Drapkina | ||
| "... was assessed by a 12-point score. Duplex ultrasound of extracranial arteries determined plaque presence ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... to the generally accepted (standard) vascular risk assessment algorithms Framingham Risk Score and Pooled Cohort ..." | ||
| Vol 7, No 4 (2011) | USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, A. V. Rudakov, T. S. Zhupanova | ||
| "... and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... and erectile function in men aged 40-65 years with high and very high cardiovascular risk. Additionally ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT | Abstract similar documents |
| V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko | ||
| "... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..." | ||
| Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
| "... with arterial hypertension (HT) of 1-2 degree and high cardiovascular risk, and to evaluate target blood ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... predictors of its effectiveness in patients with very high cardiovascular risk. Material and methods. 58 ..." | ||
| Vol 14, No 6 (2018) | Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk | Abstract PDF (Eng) similar documents |
| O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk | ||
| "... of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... ,0 mmol/l and high cardiovascular risk were involved into the study. During 5 weeks before study including ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... cardiovascular (CV) risk in real clinical practice. Material and methods. The general information of the study ..." | ||
| Vol 7, No 3 (2011) | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko | ||
| Vol 7, No 3 (2011) | VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY | Abstract similar documents |
| E. P. Trukhacheva, M. V. Ezhov | ||
| "... . These drugs therapy associates with 30% risk reduction in mortality and coronary events. However , the threat ..." | ||
| Vol 5, No 3 (2009) | CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov | ||
| "... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..." | ||
| Vol 16, No 5 (2020) | Actual Issues of the Cardiac Complications Risk Assessment and Correction in Non-Cardiac Surgery | Abstract similar documents |
| A. N. Sumin | ||
| "... for assessing cardiac risk of non-cardiac operations considering the emergence of new publications on this topic ..." | ||
| Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
| "... regression was performed to assess the independent association between risk factors and endpoints. Results ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... with high and very high cardiovascular risk. ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... Despite progress in reducing the risk of hypertension (HT) complications, control of blood ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... ) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction. Material ..." | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..." | ||
| Vol 11, No 2 (2015) | LOW SODIUM DIET: PROS AND CONS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... снижение потребления соли необходимо для коррекции высоких цифр артериального давления. Врачу не стоит ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... in a special category of patients with extremely high cardiovascular risk, as well as in patients with recent ..." | ||
| Vol 17, No 1 (2021) | Myocardial Infarction Complicated by Ischemic Stroke: Risk Factors, Prognosis, Unresolved Problems and Possible Methods of Prevention | Abstract similar documents |
| M. V. Zykov, V. V. Butsev, R. R. Suleymanov | ||
| "... and modern dual antithrombotic therapy can reduce the risk of developing cerebrovascular accident in patients ..." | ||
| Vol 10, No 6 (2014) | THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY | Abstract similar documents |
| D. A. Andreev | ||
| "... , relation of platelet reactivity with the risk of adverse events, as well as factors that contribute to high ..." | ||
| Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
| A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
| "... of dyslipidemia was not revealed. The probability of being in a group with a high atherogenic risk is 2 times ..." | ||
| Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
| "... fibrillation (AF) with the risk level of thromboembolic complications (TEC), calculated with the СHADS2 and CHA ..." | ||
| Vol 16, No 6 (2020) | Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome | Abstract similar documents |
| R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh | ||
| "... on possibilities of ischemic and hemorrhagic risks assessment. Good clinical risk metrics is based on validated ..." | ||
| Vol 12, No 2 (2016) | CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin | ||
| "... of atherosclerosis and to searching new risk factors which could help to optimize primary and secondary prevention ..." | ||
| Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
| "... концентрация холестерина липопротеинов высокой плотности – p<0,005 у всех мужчин и p≤0,05 у женщин моложе 45 ..." | ||
| Vol 20, No 3 (2024) | Digital model for predicting the risk of developing acute decompensated heart failure | Abstract similar documents |
| N. B. Lebedeva, A. P. Egle, Yu. A. Argunova, O. L. Barbarash | ||
| "... Aim. Development and external validation of a risk prediction model for acute decompensated heart ..." | ||
| Vol 20, No 2 (2024) | Risk factors of ventricular arrhythmias in non-syndromic mitral valve prolapse | Abstract similar documents |
| E. L. Trisvetova | ||
| "... ("old") risk factors and new phenomena encountered in rhythm and conduction disturbances during MVP ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..." | ||
| Vol 6, No 1 (2010) | HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION | Abstract similar documents |
| I. V. Osipova, O. N. Antropova, E. I. Bravkova, A. G. Zaltsman, T. B. Belousova, T. V. Perevozchikova, I. A. Batanina | ||
| "... with moderate-to-high cardiovascular risk were included into the open prospective uncontrolled study. The study ..." | ||
| Vol 18, No 4 (2022) | Parameters of the Infrastructure of the Residential Area and Their Relationship with Cardiovascular Risk Factors | Abstract similar documents |
| T. A. Mulerova, T. F. Gaziev, E. D. Bazdyrev, E. V. Indukaeva, D. P. Tsygankova, O. V. Nakhratova, A. S. Agienko, G. V. Artamonova | ||
| "... in Kemerovo Oblast and their connection to cardiovascular disease risk factors. Subjects and methods ..." | ||
| Vol 18, No 3 (2022) | Association of Heart Rate Variability with the Psychosocial Stress Level in Men 41-44 Years Old Living in Moscow | Abstract similar documents |
| O. M. Drapkina, V. B. Rozanov, A. V. Kontsevaya, O. Yu. Isaykina, G. A. Muromtseva, M. B. Kotova, E. S. Akarachkova | ||
| "... stress (PS) and other indicators of the risk of cardiovascular diseases in a sample of 41-44-year-old men ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... cardiovascular risk and the frequency of prescribing drugs that lower serum uric acid (sUA) levels in real ..." | ||
| Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
| D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
| "... and income, marital status) and the presence of behavioral risk factors (tobacco and alcohol use). Results ..." | ||
| Vol 14, No 4 (2018) | Association of Conventional Cardiovascular Risk Factors with Carotid Atherosclerosis Prevalence in General Population | Abstract similar documents |
| V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, S. A. Shalnova | ||
| "... and LES were associated with CAS prevalence. In multivariable regression analysis 9 risk factors appeared ..." | ||
| Vol 19, No 5 (2023) | Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region | Abstract similar documents |
| N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, T. E. Bakka, N. K. Pershina, E. S. Timoshchenko, A. A. Nekrasov, E. A. Ovchinnikova, N. N. Savickaya, M. A. Mironov, Yu. A. Balanova, A. E. Imaeva, A. V. Kontsevaya | ||
| "... survey, a questionnaire to identify chronic non-communicable diseases and related risk factors ..." | ||
| Vol 6, No 1 (2010) | HEALTH AND EDUCATION OF A PHYSICIAN: TWO PARTS OF THE SUCCESS | Abstract similar documents |
| S. Yu. Martsevich, L. Yu. Drozdova, V. P. Voronina | ||
| "... Aim. To evaluate a prevalence of cardiovascular risk factors among physicians, awareness about ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..." | ||
| Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
| "... PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..." | ||
| Vol 13, No 6 (2017) | HEART RATE AND ITS ASSOCIATION WITH THE MAIN RISK FACTORS IN THE POPULATION OF MEN AND WOMEN OF WORKING AGE | Abstract similar documents |
| S. А. Shalnov, A. D. Deev, O. A. Belova, Yu. I. Grinshtein, D. V. Duplyakov, A. Yu. Efanov, E. V. Indukaeva, N. V. Kulakova, R. A. Libis, S. V. Nedogoda, O. P. Rotar, G. V. Tolparov, I. A. Trubacheva, T. M. Chernykh, A. A. Shabunova, S. A. Boytsov | ||
| "... and metabolic risk factors, inflammation and residence in the village are found. ..." | ||
| Vol 16, No 5 (2020) | Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years | Abstract similar documents |
| S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina | ||
| "... group – BP≥140/90 mm Hg and HR>80 beats/min. Risk factors and cardiovascular history were analyzed ..." | ||
| Vol 15, No 3 (2019) | The Prevalence of Smoking in 41-43-Year-Old Males and its Relation to Some Risk Factors | Abstract PDF (Eng) similar documents |
| A. A. Alexandrov, M. V. Kotova, E. I. Ivanova, V. B. Rozanov | ||
| "... association with other chronic non-communicable diseases risk factors. Material and methods. People of male ..." | ||
| 1 - 100 of 1043 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
